Skip to content

Functional Remediation for Bipolar Disorder

Comparative Efficacy of Two Psychosocial Strategies of Intervention (Neurocognitive vs Psychoeducative) as add-on Therapy Versus Treatment as Usual in Bipolar Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01370668
Enrollment
198
Registered
2011-06-10
Start date
2009-01-31
Completion date
2010-12-31
Last updated
2011-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

functional remediation, psychoeducation, neurocognition

Brief summary

Bipolar disorder is a severe, chronic and recurrent illness, that affects nearly the 5% of the population. Recent research point at the relevance and persistence of cognitive dysfunctions in bipolar patients even beyond the acute phases, although cognitive impairment has been classically associated with schizophrenia and not bipolar disorder. Current findings suggest that some intervention is needed in order to improve not only affective symptoms but also cognitive dysfunctions, so that patients could benefit from cognitive remediation techniques to improve cognitive impairment and the functional outcome. There is no previous research on the efficacy of cognitive remediation programs on bipolar disorder.

Detailed description

The method consists of a randomized clinical trial with 3 arms: 1) one group (n=66) will receive a cognitive rehabilitation program + pharmacological treatment, 2) another group (n=66) will receive a psychoeducation program + pharmacological treatment, and 3) a control group (n=66) will only receive pharmacological treatment. A psychopathological, neuropsychological and functional assessment will be administered pre and post-intervention and a 12-month follow-up to assess the long term effects of the intervention.

Interventions

The functional remediation program is composed of 21 weekly sessions of 90 minutes, each aimed at improving the following cognitive domains: attention, memory and executive functions and psychosocial functioning. The program will be performed in an 12- to 15-patient group conducted by 2 experienced neuropsychologists with previous experience with bipolar patients and specific training on patients' group management.

BEHAVIORALPsychoeducation

Group psychoeducation is a tested and manualized intervention consisting of 21 weekly sessions of 90 minutes aimed at improving 4 main issues: illness awareness, treatment adherence, early detection of prodromal symptoms and recurrences, and lifestyle regularity.

BEHAVIORALTreatment as usual

The patients will not receive any add-on psychosocial intervention. All patients will keep on receiving standard psychiatric treatment.

Sponsors

Hospital Clinic of Barcelona
CollaboratorOTHER
Benito Menni
CollaboratorUNKNOWN
University of Valencia
CollaboratorOTHER
Hospital Universitari de Bellvitge
CollaboratorOTHER
Universidad de Oviedo
CollaboratorOTHER
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
CollaboratorOTHER
Hospital General Universitario Gregorio Marañon
CollaboratorOTHER
Hospital Santiago Apóstol de Vitoria
CollaboratorUNKNOWN
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
CollaboratorOTHER
Centro de Investigación Biomédica en Red de Salud Mental
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Outpatients * Diagnosis of bipolar disorder type I or II, according to DSM-IV-TR 4ª Ed criteria * Adult patients, aged between 18 and 55 years old * Euthymic (YMRS \< 6, HDRS \< 8) for at least three months prior to study entry. * Signed inform consent * Severe or moderate functional impairment (FAST \> 18)

Exclusion criteria

* IQ \< 85 * Neurological illness * Present diagnosis of substance abuse or dependence according to DSM-IV criteria the last three months * Significant medical illness considered as severe by the study that may interfere with assessments * having been enrolled in any kind of cognitive rehabilitation intervention the last two years

Design outcomes

Primary

MeasureTime frameDescription
Functional Assessment Short Test (FAST)BaselineThe FAST is a valid and reliable instrument, easy to apply which requires a short period of time to administer. Evaluates functioning taking into account the last 15 days. It was developed for the clinical evaluation of the main difficulties presented by psychiatric patients, and has been validated in several languages for patients with bipolar disorder. The FAST scale consists of 24 items which allow the assessment of six specific areas of functioning: autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships and leisure time.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026